Vallejo E

Language: Spanish
References: 16
Page: 99-102
PDF size: 48.41 Kb.

ABSTRACT

Residual myocardial ischemia and left ventricular systolic dysfunction are the major determinants of a patient´s prognosis after myocardial infarction. Therefore, left ventricular function and residual ischemia should be evaluated in all patients before release. Coronary angiography should be performed in uncomplicated myocardial infarction patients with significant ischemia or left ventricular dysfunction. In these cases angiography must be performed to determine if coronary arteries are suitable for revascularization before performing a test of myocardial viability. Several radionuclide approaches are currently available for the clinical evaluation of patients after myocardial infarction. There is growing and consistent evidence that the scintigraphic approaches are the most sensitive technique to investigate the presence of ischemia or tissue viability and also to provide an accurate and reproducible evaluation of the left ventricular function. Most importantly, radionuclide evaluation in these patients provide valuable prognostic information. However, the number of patients with malignant arrhythmia’s detected with routine evaluation is lower at this time. In several reports neuroadrenergic imaging evaluation with I-123-MIBG was predictive of sudden death. In consequence, it has been proposed that cardiac SPECT images with I-123-MIBG may provide important prognostic information in patients with uncomplicated myocardial infarction. Therefore it is not surprising that the incorporation of new radionuclide techniques may improve the evaluation of patients after myocardial infarction.

REFERENCES

1. Candell RJ: Estratificación pronóstica tras infarto agudo de miocardio. Rev Esp Cardiol 2003; 56: 303-13.

2. Bar Harbor meeting 2000 of the American Society of Nuclear Cardiology. J Nucl Cardiol 2001; 8: 224-316.

3. Verani MS: Risk stratifying patients who survive an acute myocardial infarction. J Nucl Cardiol 1998; 5: 96-108.

4. Candell-Riera J, Castell-Conesa J, Jurado-López JA, López de Sá E, Nuño de la Rosa JA, et al: Guías de actuación clínica de la Sociedad Española de Cardiología. Cardiología Nuclear: Bases y aplicaciones clínicas. Rev Esp Cardiol 1999; 52: 957-89.

5. Gould KL: Assessing Myocardial Viability. En: Coronary Artery Stenosis and reversing atherosclerosis. 2ª Ed. New York. Oxford University Press, 1999: 329-357.

6. Klocke FJ, Baird MG, Udelson JE, Verani MS, Williams KA: ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: a report of the American College of Cardiology/American Heart Association task force practice guidelines 2003. http://www.acc.org/clinical/guidelines/radio/rni_fulltext.pdf.

7. Sharir T, Germano G, Kavanagh PB, Berman D: Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-42.

8. Vallejo E, Chaya H, Plancarte G, Victoria D, Bialostozky D: Variability of serial same-day left ventricular ejection fraction using quantitative gated SPECT. J Nucl Cardiol 2002; 9: 377-84.

9. Wackers FJTh, Berger H, Johnstone D, Goldman L, Reduto LA, Langou RA, et al: Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 1979; 43: 1159-66.

10. Fauchier L, Marie O, Casset-Senon D, Babuty D, Cosnay P, Faucier JP: Interventricular and intraventricular dyssynchrony in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2002; 40: 2022-30.

11. Vallejo E, Jiménez L, Hernández S, Rodríguez G, Sánchez G, Bialostozky D: Evaluación de la secuencia de contracción ventricular con ventriculografía radioisotópica en equilibrio: utilidad del análisis de fase. XXIII Congreso Nacional de Cardiología, Monterrey, N.L., Noviembre de 2003.

12. Levine MG, McGill CC, Ahlberg AW: Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999; 83: 1-5.

13. DiCarli M: Assessment of myocardial viability after myocardial infarction. J Nucl Cardiol 2002; 9: 229-35.

14. Sisson JC, Shapiro B, Myers L, Mallette S, Mangner TJ, Wieland DM, et al: Metaiodobenzylguanidina to map scintigraphically the adrenergic nervous system in man. J Nucl Med 1987; 28: 1625-36.

15. Stanton MS, Tuli MM, Radtke NL, Heger JJ, Miles WM, Mock BH, et al: Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1989; 14: 1519-26.

16. Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al: Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000; 101: 2579-2585.